A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Revised Hypertrophic Scars
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 21 - 55 |
| Updated: | 2/24/2018 |
| Start Date: | July 2014 |
| End Date: | March 2018 |
An Open-Label, Multi-Center, Prospective, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery for Hypertrophic Scars in Healthy Adults
The purpose of this study is to determine the effectiveness of RXI-109 in reducing the
recurrence of hypertrophic scar formation following elective revision of a pre-existing
hypertrophic scar.
recurrence of hypertrophic scar formation following elective revision of a pre-existing
hypertrophic scar.
Inclusion Criteria:
- Adults, 21-55 years of age
- General good health
- Previous surgery or injury resulting in a hypertrophic scar
Exclusion Criteria:
- Scars on the face or front of neck may not be included in the trial
- Use of tobacco or nicotine-containing products
- Pregnant or lactating
We found this trial at
6
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials